Aquaporins in Immune Cells and Inflammation: New Targets for Drug Development

被引:43
|
作者
da Silva, Ines, V [1 ,2 ]
Soveral, Graca [1 ,2 ]
机构
[1] Univ Lisbon, Fac Pharm, Res Inst Med iMed ULisboa, P-1649003 Lisbon, Portugal
[2] Univ Lisbon, Fac Pharm, Dept Pharmaceut Sci & Med, P-1649003 Lisbon, Portugal
关键词
aquaporins; immune cells; immunity; inflammation; inflammatory disease; HYDROGEN-PEROXIDE; WATER CHANNELS; DOWN-REGULATION; EXPERIMENTAL COLITIS; CEREBRAL EDEMA; LUNG INJURY; RAT MODEL; EXPRESSION; ENDOTOXEMIA; TRANSPORT;
D O I
10.3390/ijms22041845
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian immune system senses foreign antigens by mechanisms that involve the interplay of various kinds of immune cells, culminating in inflammation resolution and tissue clearance. The ability of the immune cells to communicate (via chemokines) and to shift shape for migration, phagocytosis or antigen uptake is mainly supported by critical proteins such as aquaporins (AQPs) that regulate water fluid homeostasis and volume changes. AQPs are protein channels that facilitate water and small uncharged molecules' (such as glycerol or hydrogen peroxide) diffusion through membranes. A number of AQP isoforms were found upregulated in inflammatory conditions and are considered essential for the migration and survival of immune cells. The present review updates information on AQPs' involvement in immunity and inflammatory processes, highlighting their role as crucial players and promising targets for drug discovery.
引用
收藏
页码:1 / 16
页数:15
相关论文
共 50 条
  • [31] Intermittent Claudication: New Targets for Drug Development
    Eric P. Brass
    Drugs, 2013, 73 : 999 - 1014
  • [32] Drug targets in inflammation and immunomodulation
    Buckle, DR
    Hedgecock, CJR
    DRUG DISCOVERY TODAY, 1997, 2 (08) : 325 - 332
  • [33] Immune cells that remember inflammation could offer treatment targets for atherosclerosis
    Amanda B. Keener
    Nature, 2021, 594 (7862) : S10 - S11
  • [34] Chemical signatures and new drug targets for gametocytocidal drug development
    Wei Sun
    Takeshi Q. Tanaka
    Crystal T. Magle
    Wenwei Huang
    Noel Southall
    Ruili Huang
    Seameen J. Dehdashti
    John C. McKew
    Kim C. Williamson
    Wei Zheng
    Scientific Reports, 4
  • [35] Inflammation and cancer: immune cells as targets for anti-cancer therapy
    Coussens, Lisa M.
    CLINICAL & EXPERIMENTAL METASTASIS, 2015, 32 (03) : 182 - 182
  • [36] Chemical signatures and new drug targets for gametocytocidal drug development
    Sun, Wei
    Tanaka, Takeshi Q.
    Magle, Crystal T.
    Huang, Wenwei
    Southall, Noel
    Huang, Ruili
    Dehdashti, Seameen J.
    McKew, John C.
    Williamson, Kim C.
    Zheng, Wei
    SCIENTIFIC REPORTS, 2014, 4
  • [37] PLATELET-ACTIVATING-FACTOR AND INFLAMMATION IN ATHEROGENESIS - TARGETS FOR DRUG DEVELOPMENT
    HANDLEY, DA
    SAUNDERS, RN
    DRUG DEVELOPMENT RESEARCH, 1986, 7 (04) : 361 - 375
  • [38] Inflammation and the glutamate system in schizophrenia: implications for therapeutic targets and drug development
    Mueller, Norbert
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (12) : 1497 - 1507
  • [39] Aquaporins in immune cells: contribution for inflammasome priming and activation
    da Silva, I. V.
    Cardoso, C.
    Martinez-Banaclocha, H.
    Casini, A.
    Pelegrin, P.
    Soveral, G.
    FEBS OPEN BIO, 2019, 9 : 71 - 72
  • [40] Potential new targets for drug development in severe asthma
    Zhu, Linda
    Ciaccio, Christina E.
    Casale, Thomas B.
    WORLD ALLERGY ORGANIZATION JOURNAL, 2018, 11